This week's Fierce Pharma is brought to you by Helix.

The Future of Precision Medicine: Leveraging Clinico-Genomic Data for Germline Disorders

Wednesday, April 24, 2024 | 12:30pm ET / 10:30am PT

During this discussion, experts will share methods foridentifying promising drug targets and biomarkers by leveraging linked clinico-genomic data in advancing therapeutic development and its application from research to clinical care.

Insights offered in this discussion:  

• Examine how linked clinico-genomic data can help better understand complex disease mechanisms to enable the development of targeted therapeutics with better safety and efficacy profiles
• Leverage these datasets to support the identification and stratification of diverse patient populations that are more likely to respond to targeted therapeutics
• Understand the health research perspective on how genetic medicines are translated into clinical care especially in cardiovascular diseases
• Explore real-world examples where precision medicine has impacted drug development